Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Lecithin-based nanoparticle adjuvant induces antibody immune responses

Jan. 20, 2010

mTOR inhibition restores age-impaired hematopoietic stem cell function

Jan. 19, 2010

Pfizer provides U.S. regulatory update on Prevnar 13 vaccine

Jan. 4, 2010

LifeCycle submits phase III protocol for LCP-Tacro trial to the FDA

Dec. 30, 2009

ImmuneRegen reports efficacy for its new adjuvant of a preventive cancer vaccine

Dec. 28, 2009

NOS-2 inhibitors disclosed by Brazilian scientists for the treatment of inflammatory disorders

Dec. 22, 2009

Novel ZAP-70 inhibitors in early development at Cellzone

Dec. 10, 2009

Novel S1P1/edg1 receptor agonists in early development at Actelion

Dec. 9, 2009

Glucocorticoid receptor modulators disclosed by Ligand as anti-inflammatory agents

Dec. 2, 2009

Latin American studies show potential of hexavalent Hexaxim vaccine

Dec. 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...